|Articles|July 2, 2003
- Pharmaceutical Technology-07-02-2003
- Volume 27
- Issue 7
Understanding and Implementing a Risk-Based Approach to 21 CFR Part 11 Compliance
Pharmaceutical companies must take a holistic look at their systems and supporting processes to implement FDA's risk-based approach into their 21 CFR Part 11 complaince strategies.
Advertisement
Articles in this issue
over 22 years ago
July 2003over 22 years ago
The Push for Generics Challenges Manufacturersover 22 years ago
Emerging Research Opportunities in Oral Inhalation Technologyover 22 years ago
Preventing Metal Contaminationover 22 years ago
Capacity Worries Fade for BiomanufacturingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
5
